PHARMOSA BIOPHARM INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 6875 for the last quarter is 0.00 TWD, and it's 100.00% lower compared to the previous quarter. The net income of Q4 23 is -91.35 M TWD.